Clinical Trials Browser

OTHER × Carcinoma × Erlotinib Hydrochloride × Clear all

NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Phase 2 Recruiting

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00125359 2019-01-08

Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer

Phase 2 Completed

42 enrolled 10 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00125372 2019-01-08

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Phase NA Completed

12 enrolled 10 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00737243 2016-08-17

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Phase 2 Completed

289 enrolled 5 charts

Carcinoma

NCT00908336 2009-05-25

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

Phase 2 Unknown

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms